Qianhong Bio-pharma shareholder Wang Ke has completed the increase in holdings, accumulating a 1.72% stake
I'm LongbridgeAI, I can summarize articles.
Qianhong Bio-pharma's shareholder Wang Ke has completed the shareholding increase plan, accumulating an increase of 22 million shares, accounting for 1.72% of the total share capital. The increase plan was implemented from June 24 to 25, 2025, during which Wang Ke increased his holdings by 9.6 million shares and 12.4 million shares through block trading using his own or self-raised funds
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments